Improving smoking cessation programs for people living with HIV in South Africa.
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
['FUNDING_U01'] · JOHNS HOPKINS UNIVERSITY · NIH-10911263
This study is looking to find better ways to help people with HIV in South Africa quit smoking by testing effective methods that have worked before, making sure they fit well with local healthcare, and getting input from patients to meet their needs.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10911263 on ClinicalTrials.gov |
What this research studies
This research aims to enhance smoking cessation efforts for individuals living with HIV in South Africa by assessing the effectiveness, implementation, and cost-efficiency of proven smoking cessation strategies. The project focuses on a population that faces high rates of smoking and related health issues, including tuberculosis and cardiovascular diseases. By evaluating existing interventions that have worked in similar low-resource environments, the research seeks to develop tailored approaches that can be integrated into local healthcare practices. Patients will be involved in the evaluation process to ensure that the interventions meet their needs and are feasible within the healthcare system.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are living with HIV and currently smoke tobacco.
Not a fit: Patients who do not smoke or are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve health outcomes for people living with HIV by reducing smoking-related diseases and enhancing overall well-being.
How similar studies have performed: Previous research has shown success with similar smoking cessation interventions in low-resource settings, indicating a promising approach for this population.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOLUB, JONATHAN E. — JOHNS HOPKINS UNIVERSITY
- Study coordinator: GOLUB, JONATHAN E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus